NUAK1 and cancer: The phosphorylation of MYPT at S445 by NUAK1 increases the activity of GSK3β for NRF2 and suppresses the cellular ROS response thereby reducing the capacity of cancer cells to maintain adaptation to high ROS production (Port et al., 2018).